Join to View Full Profile
1365 Clifton RoadAtlanta, GA 30322
Dr. Goswamy is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Rohit Goswamy is an oncology specialist based in Atlanta, GA, with subspecialty training in hematologic oncology. He is currently a Hematology/Oncology Fellow at Emory University School of Medicine, where he has been since 2022. He completed his fellowship in Hematology and Medical Oncology at Emory University and his residency and chief residency in Internal Medicine at the University of Texas Health Science Center at Houston. Dr. Goswamy graduated from the Royal College of Surgeons in Ireland - Medical University of Bahrain in 2017. He has published several papers in notable journals such as Clinical Cancer Research and Frontiers in Oncology and has earned honors, including being named Chief Resident and election to the Alpha Omega Alpha Honor Medical Society.
Education & Training
Emory University School of MedicineFellowship, Hematology and Medical Oncology, 2022 - 2025
University of Texas Health Science Center at HoustonChief Residency, Internal Medicine, 2021 - 2022- University of Texas Health Science Center at HoustonResidency, Internal Medicine, 2018 - 2021
Royal College of Surgeons in Ireland - Medical University of BahrainClass of 2017
Certifications & Licensure
TX State Medical License 2021 - 2026
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Chief Resident University of Texas Health Science Center at Houston, 2021-2022
- Alpha Omega Alpha 2021
Publications & Presentations
PubMed
- Real-World Outcomes in Patients with Advanced Penile Squamous Cell Carcinoma Receiving Immune Checkpoint Inhibitors: A Single Institution Experience.Tony Z Zhuang, Subir Goyal, Katherine B Case, T Anders Olsen, Shalini Vemuru
Journal of Immunotherapy and Precision Oncology. 2025-02-01 - Association of baseline inflammatory biomarkers and clinical outcomes in patients with advanced renal cell carcinoma treated with immune checkpoint inhibitors.Ahmet Yildirim, Mengting Wei, Yuan Liu, Bassel Nazha, Jacqueline T Brown
Therapeutic Advances in Medical Oncology. 2025-01-01 - Ataxia-Telangiectasia Mutated Loss-of-Function Displays Variant and Tissue-Specific Differences across Tumor Types.Patrick G Pilié, Virginia Giuliani, Wei-Lien Wang, Daniel J McGrail, Christopher A Bristow
Clinical Cancer Research. 2024-05-15
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
